In Just Over a Year, the Consumer Has Changed
Today’s healthcare consumer is more digitally empowered, more skeptical, more informed, and increasingly influenced by artificial intelligence. They are researching symptoms before appointments, evaluating treatment options independently, and arriving at physician visits armed with information gathered from search engines, social media, patient communities, and AI-powered tools. For pharma marketers, understanding these behavioral shifts is no longer optional. It is essential for creating effective, compliant, and trusted engagement.
The New Healthcare Consumer Is Researching Before They Reach the Doctor
Patients are taking greater ownership of their healthcare journeys. According to Gallup, 59% of Americans who use AI for health information report doing so before visiting a healthcare provider. The technology is becoming a preliminary research tool rather than a post-visit resource.
This behavior reflects a broader trend toward self-directed health education. Consumers increasingly want answers immediately, often before scheduling an appointment or speaking with a physician. For DTC marketers, this means the patient journey often begins long before a healthcare professional enters the conversation.
The implication is clear: brands must provide educational content that supports patients during the earliest stages of information-seeking, when they are still forming perceptions of symptoms, disease states, and treatment options.
AI Has Become the New Front Door to Healthcare Information
Perhaps the most significant change since 2024 is the rise of generative AI as a healthcare information source. A 2026 KFF Tracking Poll found that Americans are now turning to AI for health information at rates comparable to social media. Among users, 65% cited the desire for immediate answers as a major reason for using AI tools, while 41% wanted information before seeing a provider.
Meanwhile, Rock Health data found that 32% of consumers used AI chatbots to find health information in 2025, up from 16% in 2024. This represents a fundamental shift in how healthcare information is discovered.
For years, marketers optimized content for Google search. Increasingly, consumers are asking questions directly to ChatGPT, Gemini, Claude, and AI-enhanced search engines. As a result, pharmaceutical marketers must think beyond traditional SEO and consider how their educational content, disease information, and evidence-based resources are surfaced, cited, and interpreted by AI systems.
Trust Has Become More Complicated
One of the most interesting paradoxes in healthcare today is that consumers simultaneously trust and distrust AI. KFF found that 77% of Americans are concerned about the privacy of medical information shared with AI tools. Yet consumers continue using these platforms because they provide speed, convenience, and accessibility.
Research from the Annenberg Public Policy Center found that nearly 8 in 10 adults would likely go online for answers to health questions, and among those users, almost 2/3 reported encountering AI-generated responses. Most considered those responses useful and reliable.
Academic research has also shown that people often struggle to distinguish AI-generated medical information from physician-generated information and may rate AI responses as equally—or even more—trustworthy.
For marketers, this creates a new challenge. Trust is no longer earned simply through brand recognition. It is earned through transparency, credibility, evidence, and consistency across every digital touchpoint. Consumers are evaluating information from multiple sources simultaneously and comparing what brands say with what physicians, patient communities, media outlets, and AI systems say.
Consumers Expect More Personalization
Healthcare is increasingly behaving like every other consumer industry. Patients expect personalized experiences, digital convenience, and communications that reflect their specific needs. PwC’s 2025 Healthcare Consumer Insights Survey describes healthcare as entering a “consumer-first era,” where rising expectations are reshaping how organizations engage patients.
Consumers are no longer comparing healthcare experiences only against other healthcare experiences. They are comparing them against Amazon, Netflix, Uber, and every other highly personalized digital interaction in their lives.
This means DTC marketing strategies built around broad demographic segments may become less effective than approaches centered on patient intent, behavior, and specific informational needs.
Access and Affordability Are Driving Behavior
Another important shift is that many consumers are turning to digital tools as healthcare access remains challenging. Among AI users seeking health information, younger adults and lower-income populations frequently cite difficulty accessing or affording healthcare services as a reason for turning to AI.
This trend suggests that many consumers are not simply seeking convenience. They are attempting to fill gaps in the healthcare system. For pharma marketers, this highlights the importance of addressing practical concerns alongside clinical education:
- Cost and affordability
- Insurance coverage
- Access programs
- Patient support services
- Treatment navigation
Messages focused exclusively on efficacy may miss what patients are actually trying to solve.
The Physician Remains Critical—But No Longer Controls the Entire Conversation
Despite rapid growth in digital health information seeking, physicians remain highly influential. The difference is that they are no longer the sole source of information. Patients increasingly arrive with pre-formed opinions, research, and treatment questions generated through online and AI-assisted exploration. Healthcare professionals are adapting to visits that begin with, “I read…” or “ChatGPT suggested…” rather than “What should I know?”
For pharma marketers, the opportunity is not to replace the physician’s role but to support more productive conversations between patients and providers. The brands that succeed will be those that help consumers become better informed while reinforcing the importance of professional medical guidance.
What DTC Marketers Should Do Now
The healthcare consumer of 2026 is fundamentally different from that of 2024.
They are:
- More proactive about managing their health
- More likely to use AI as a health information source
- More demanding of personalized experiences
- More skeptical of traditional marketing claims
- More focused on access, convenience, and affordability
- More likely to engage with multiple information sources before speaking with a physician
The most effective pharmaceutical marketers will respond by shifting from campaign-centric thinking to consumer-centric thinking. Success will depend less on delivering a message and more on earning trust, providing credible education, and meeting consumers wherever they choose to begin their healthcare journey.
Because today, that journey may not start with a physician’s office or a search engine. It may start with a question asked to an AI assistant.
